Clinical Trial Update: Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and tolerability of AZD2281 (olaparib) in combination with bevacizumab in patients with advanced solid tumors; the trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• AZD2281 (olaparib)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasm Metastasis | Phase 1 | Status: COMPLETED